Technology — Page 32
- ByteDance and Alibaba pull AI companions as Beijing may make spontaneity costly
- Hayabusa2 completes Torifune flyby on long asteroid route
- Z.ai challenges US AI rivals with cheaper GLM-5.2
- Baillie Gifford argues delayed IPOs push investors into private lockups
- Drug discovery labs face margin pressure as bioRxiv preprint claims high-throughput GAG profiling
- Colorectal cancer labs may face higher data costs as bioRxiv preprint claims early immune split
- Neuroprosthetic makers face a preprint claiming brains decide before behavior shows
- Baillie Gifford says emerging-market buyers face pricier AI chip sourcing
- Emerging markets need local AI, putting foreign vendors on notice
- Indian hospitals may see AI clinical software reshape public tech buying
- Clinical labs face margin squeeze as bioRxiv preprint reports single-sample AMR workflow
- Proteomics labs face a bioRxiv claim that methylation atlases lower false-discovery work
- CG SEMI’s Gujarat plant start tests India’s OSAT margin ambitions
- India’s Geneva AI talks put compliance teams on a standards watch
- Indian electronics buyers may face narrower chip choice as CG Power targets 16 million daily
- CG Power ships first India chips from Sanand
- Small businesses can swap fixed labor costs for AI subscriptions
- Gurugram firings expose civic AI fraud costs municipalities have underpriced
- Indian equities could turn AI selloff into Asia stability rules for capital
- CG Power JV output puts Indian electronics buyers on a new sourcing clock
- India-UK CETA says AI firms get a trade pact, not just tariff relief
- Bitcoin 58 bin dolara inerken büyük yatırımcılar temkinli
- Data center buyers may push utilities toward local power, Baillie Gifford argues
- Fund managers may face tougher AI scrutiny after Baillie Gifford letter
- Baillie Gifford says AI winners must prove value beyond pilots
- Apple wearable appears in iOS 27 code
- AI app teams could lose benchmark control as Stack Overflow points to open metrics
- Gujarat draws Rs 1.24 lakh crore for chip projects
- Epigenetics labs see a preprint claiming spatial maps from pooled proteomics
- SCALE preprint claims antibody datasets may squeeze drug discovery margins
- bioRxiv preprint claims raw-count inputs could simplify single-cell omics work
- bioRxiv preprint claims antibody retrieval can narrow wet-lab screening
- BioRxiv preprint claims biology labs can move more hypothesis work into software
- MARVIN preprint claims automated cell phenotyping could squeeze lab analysis margins
- TCS and Infosys market-cap slide pressures India IT staffing margins
- Indian developers face AI platform pressure after NAREDCO conclave claims consensus
- Ashwini Vaishnaw’s 2027 rail target tests India’s high-tech procurement plans
- Drug discovery teams get a preprint claiming new enzyme structures shift screening costs
- Prof Arun Mohan Sherry’s AI focus puts B-school faculty hiring under pressure
- Bain says India’s AI startups face a profit test as VC patience narrows